Tullio Palmerini, MD

Neurological Disorders and Diseases
Neurological Disorders and Diseases
03/19/2012
Beverly N. Greenspan, PhD, MD; Tullio Palmerini, MD
Currently approved pharmacological treatments for AD consist of central cholinesterase inhibitors and memantine, whose benefits are modest but well documented.
03/19/2012
Neurological Disorders and Diseases
Neurological Disorders and Diseases
03/19/2012
Beverly N. Greenspan, PhD, MD; Tullio Palmerini, MD
Currently approved pharmacological treatments for AD consist of central cholinesterase inhibitors and memantine, whose benefits are modest but well documented.
03/19/2012